489 related articles for article (PubMed ID: 15452177)
1. Coordinate expression and trans presentation of interleukin (IL)-15Ralpha and IL-15 supports natural killer cell and memory CD8+ T cell homeostasis.
Burkett PR; Koka R; Chien M; Chai S; Boone DL; Ma A
J Exp Med; 2004 Oct; 200(7):825-34. PubMed ID: 15452177
[TBL] [Abstract][Full Text] [Related]
2. Interleukin (IL)-15R[alpha]-deficient natural killer cells survive in normal but not IL-15R[alpha]-deficient mice.
Koka R; Burkett PR; Chien M; Chai S; Chan F; Lodolce JP; Boone DL; Ma A
J Exp Med; 2003 Apr; 197(8):977-84. PubMed ID: 12695489
[TBL] [Abstract][Full Text] [Related]
3. NKTR-255 is a polymer-conjugated IL-15 with unique mechanisms of action on T and natural killer cells.
Robinson TO; Hegde SM; Chang A; Gangadharan A; Rivas S; Madakamutil L; Zalevsky J; Miyazaki T; Schluns KS
J Clin Invest; 2021 Oct; 131(19):. PubMed ID: 34375310
[TBL] [Abstract][Full Text] [Related]
4. Transregulation of memory CD8 T-cell proliferation by IL-15Ralpha+ bone marrow-derived cells.
Schluns KS; Klonowski KD; Lefrançois L
Blood; 2004 Feb; 103(3):988-94. PubMed ID: 14512307
[TBL] [Abstract][Full Text] [Related]
5. Different NK cell developmental events require different levels of IL-15 trans-presentation.
Lee GA; Liou YH; Wang SW; Ko KL; Jiang ST; Liao NS
J Immunol; 2011 Aug; 187(3):1212-21. PubMed ID: 21715685
[TBL] [Abstract][Full Text] [Related]
6. Cutting edge: transpresentation of IL-15 by bone marrow-derived cells necessitates expression of IL-15 and IL-15R alpha by the same cells.
Sandau MM; Schluns KS; Lefrancois L; Jameson SC
J Immunol; 2004 Dec; 173(11):6537-41. PubMed ID: 15557143
[TBL] [Abstract][Full Text] [Related]
7. T cell-independent interleukin 15Ralpha signals are required for bystander proliferation.
Lodolce JP; Burkett PR; Boone DL; Chien M; Ma A
J Exp Med; 2001 Oct; 194(8):1187-94. PubMed ID: 11602647
[TBL] [Abstract][Full Text] [Related]
8. IL-15 can signal via IL-15Rα, JNK, and NF-κB to drive RANTES production by myeloid cells.
Chenoweth MJ; Mian MF; Barra NG; Alain T; Sonenberg N; Bramson J; Lichty BD; Richards CD; Ma A; Ashkar AA
J Immunol; 2012 May; 188(9):4149-57. PubMed ID: 22447977
[TBL] [Abstract][Full Text] [Related]
9. Homeostatic proliferation but not the generation of virus specific memory CD8 T cells is impaired in the absence of IL-15 or IL-15Ralpha.
Wherry EJ; Becker TC; Boone D; Kaja MK; Ma A; Ahmed R
Adv Exp Med Biol; 2002; 512():165-75. PubMed ID: 12405201
[TBL] [Abstract][Full Text] [Related]
10. IL-15/IL-15Ralpha-mediated avidity maturation of memory CD8+ T cells.
Oh S; Perera LP; Burke DS; Waldmann TA; Berzofsky JA
Proc Natl Acad Sci U S A; 2004 Oct; 101(42):15154-9. PubMed ID: 15477598
[TBL] [Abstract][Full Text] [Related]
11. Differential roles for IL-15R alpha-chain in NK cell development and Ly-49 induction.
Kawamura T; Koka R; Ma A; Kumar V
J Immunol; 2003 Nov; 171(10):5085-90. PubMed ID: 14607906
[TBL] [Abstract][Full Text] [Related]
12. IL-15R alpha-IgG1-Fc enhances IL-2 and IL-15 anti-tumor action through NK and CD8+ T cells proliferation and activation.
Wu Z; Xu Y
J Mol Cell Biol; 2010 Aug; 2(4):217-22. PubMed ID: 20671116
[TBL] [Abstract][Full Text] [Related]
13. Increasing the biological activity of IL-2 and IL-15 through complexing with anti-IL-2 mAbs and IL-15Rα-Fc chimera.
Votavova P; Tomala J; Kovar M
Immunol Lett; 2014; 159(1-2):1-10. PubMed ID: 24512738
[TBL] [Abstract][Full Text] [Related]
14. No requirement of trans presentations of IL-15 for human CD8 T cell proliferation.
Ota N; Takase M; Uchiyama H; Olsen SK; Kanagawa O
J Immunol; 2010 Nov; 185(10):6041-8. PubMed ID: 20926799
[TBL] [Abstract][Full Text] [Related]
15. Treatment with soluble interleukin-15Ralpha exacerbates intracellular parasitic infection by blocking the development of memory CD8+ T cell response.
Khan IA; Moretto M; Wei XQ; Williams M; Schwartzman JD; Liew FY
J Exp Med; 2002 Jun; 195(11):1463-70. PubMed ID: 12045244
[TBL] [Abstract][Full Text] [Related]
16. Preassociation of IL-15 with IL-15R alpha-IgG1-Fc enhances its activity on proliferation of NK and CD8+/CD44high T cells and its antitumor action.
Dubois S; Patel HJ; Zhang M; Waldmann TA; Müller JR
J Immunol; 2008 Feb; 180(4):2099-106. PubMed ID: 18250415
[TBL] [Abstract][Full Text] [Related]
17. IL-15 receptor maintains lymphoid homeostasis by supporting lymphocyte homing and proliferation.
Lodolce JP; Boone DL; Chai S; Swain RE; Dassopoulos T; Trettin S; Ma A
Immunity; 1998 Nov; 9(5):669-76. PubMed ID: 9846488
[TBL] [Abstract][Full Text] [Related]
18. Distinct cell types control lymphoid subset development by means of IL-15 and IL-15 receptor alpha expression.
Schluns KS; Nowak EC; Cabrera-Hernandez A; Puddington L; Lefrançois L; Aguila HL
Proc Natl Acad Sci U S A; 2004 Apr; 101(15):5616-21. PubMed ID: 15060278
[TBL] [Abstract][Full Text] [Related]
19. Combined IL-15/IL-15Ralpha immunotherapy maximizes IL-15 activity in vivo.
Stoklasek TA; Schluns KS; Lefrançois L
J Immunol; 2006 Nov; 177(9):6072-80. PubMed ID: 17056533
[TBL] [Abstract][Full Text] [Related]
20. Cutting edge: murine dendritic cells require IL-15R alpha to prime NK cells.
Koka R; Burkett P; Chien M; Chai S; Boone DL; Ma A
J Immunol; 2004 Sep; 173(6):3594-8. PubMed ID: 15356102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
